Medican Alpha, Medican, Mediflon, Mediflon Quick, Medican Alpha Safety, Medican Safety, Mediflon Safety, Mediflon Safety Quick, Medican Alpha Safety Pro, Medican Safety Pro, Mediflon Safety Pro, Neocan, Enfancie, Neocan safety, Enfancie Safety
Global Medikit Limited · Decision date Nov 5, 2026
What did the FDA decide?
FDA records K260631 as a 510(k) premarket notification, with a decision dated Nov 5, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General Hospital
- Decision date
- Nov 5, 2026
Regulatory record facts
- Identifier
- K260631
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Global Medikit Limited
- Product code
- FOZ
- Decision code
- SESE
- Decision date
- Nov 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days.
- Applicant
- Global Medikit Limited
- Product code
- FOZ
- FDA device class
- 2
FDA decision timeline
K260631 received
Application receipt date recorded by FDA.
K260631 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FOZ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Ruby Intravascular CatheterK260432 | Venocare, Inc. | 510(k) clearance | Sep 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Global Medikit Limited
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Dehradun
Sources and methodology
- Original FDA record: K260631
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records